BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 22558190)

  • 1. Serum levels of advanced glycation endproducts and other markers of protein damage in early diabetic nephropathy in type 1 diabetes.
    Perkins BA; Rabbani N; Weston A; Ficociello LH; Adaikalakoteswari A; Niewczas M; Warram J; Krolewski AS; Thornalley P
    PLoS One; 2012; 7(4):e35655. PubMed ID: 22558190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High fractional excretion of glycation adducts is associated with subsequent early decline in renal function in type 1 diabetes.
    Perkins BA; Rabbani N; Weston A; Adaikalakoteswari A; Lee JA; Lovblom LE; Cardinez N; Thornalley PJ
    Sci Rep; 2020 Jul; 10(1):12709. PubMed ID: 32728119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cystatin C and cystatin glomerular filtration rate as markers of early renal disease in Asian Indian subjects with glucose intolerance (CURES-32).
    Surendar J; Anuradha S; Ashley B; Balasubramanyam M; Aravindhan V; Rema M; Mohan V
    Metab Syndr Relat Disord; 2009 Oct; 7(5):419-25. PubMed ID: 19419268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-normal serum uric acid is associated with impaired glomerular filtration rate in nonproteinuric patients with type 1 diabetes.
    Rosolowsky ET; Ficociello LH; Maselli NJ; Niewczas MA; Binns AL; Roshan B; Warram JH; Krolewski AS
    Clin J Am Soc Nephrol; 2008 May; 3(3):706-13. PubMed ID: 18272826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symmetric dimethylarginine, an endogenous marker of glomerular filtration rate, and the risk for microalbuminuria in young people with type 1 diabetes.
    Marcovecchio ML; Dalton RN; Turner C; Prevost AT; Widmer B; Amin R; Dunger DB
    Arch Dis Child; 2010 Feb; 95(2):119-24. PubMed ID: 19948509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microalbuminuria and the risk for early progressive renal function decline in type 1 diabetes.
    Perkins BA; Ficociello LH; Ostrander BE; Silva KH; Weinberg J; Warram JH; Krolewski AS
    J Am Soc Nephrol; 2007 Apr; 18(4):1353-61. PubMed ID: 17329575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early progressive renal decline precedes the onset of microalbuminuria and its progression to macroalbuminuria.
    Krolewski AS; Niewczas MA; Skupien J; Gohda T; Smiles A; Eckfeldt JH; Doria A; Warram JH
    Diabetes Care; 2014; 37(1):226-34. PubMed ID: 23939543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced glycation endproducts, dityrosine and arginine transporter dysfunction in autism - a source of biomarkers for clinical diagnosis.
    Anwar A; Abruzzo PM; Pasha S; Rajpoot K; Bolotta A; Ghezzo A; Marini M; Posar A; Visconti P; Thornalley PJ; Rabbani N
    Mol Autism; 2018; 9():3. PubMed ID: 29479405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stable glomerular filtration rate in normotensive IDDM patients with stable microalbuminuria. A 5-year prospective study.
    Mathiesen ER; Feldt-Rasmussen B; Hommel E; Deckert T; Parving HH
    Diabetes Care; 1997 Mar; 20(3):286-9. PubMed ID: 9051373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent renal hypertrophy and faster decline of glomerular filtration rate precede the development of microalbuminuria in type 1 diabetes.
    Zerbini G; Bonfanti R; Meschi F; Bognetti E; Paesano PL; Gianolli L; Querques M; Maestroni A; Calori G; Del Maschio A; Fazio F; Luzi L; Chiumello G
    Diabetes; 2006 Sep; 55(9):2620-5. PubMed ID: 16936212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum concentrations of markers of TNFalpha and Fas-mediated pathways and renal function in nonproteinuric patients with type 1 diabetes.
    Niewczas MA; Ficociello LH; Johnson AC; Walker W; Rosolowsky ET; Roshan B; Warram JH; Krolewski AS
    Clin J Am Soc Nephrol; 2009 Jan; 4(1):62-70. PubMed ID: 19073786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NGAL and cystatin C: two possible early markers of diabetic nephropathy in young patients with type 1 diabetes mellitus: one year follow up.
    Papadopoulou-Marketou N; Skevaki C; Kosteria I; Peppa M; Chrousos GP; Papassotiriou I; Kanaka-Gantenbein C
    Hormones (Athens); 2015; 14(2):232-40. PubMed ID: 25402375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary Cyclophilin A and serum Cystatin C as biomarkers for diabetic nephropathy in children with type 1 diabetes.
    Salem NA; El Helaly RM; Ali IM; Ebrahim HAA; Alayooti MM; El Domiaty HA; Aboelenin HM
    Pediatr Diabetes; 2020 Aug; 21(5):846-855. PubMed ID: 32304131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystatin-C and TGF-β levels in patients with diabetic nephropathy.
    Takir M; Unal AD; Kostek O; Bayraktar N; Demirag NG
    Nefrologia; 2016; 36(6):653-659. PubMed ID: 27745866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Matrix Metalloproteinase-3 Activity and Glomerular Filtration Rate and Albuminuria Status in Patients With Type 2 Diabetes Mellitus.
    Amanzadeh M; Mota A; Zarghami N; Abedi-Azar S; Abroon S; Akbarian N; Mihanfar A; Rahmati-Yamchi M
    Iran J Kidney Dis; 2018 Jan; 12(1):40-47. PubMed ID: 29421776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac autonomic neuropathy and early progressive renal decline in patients with nonmacroalbuminuric type 1 diabetes.
    Orlov S; Cherney DZ; Pop-Busui R; Lovblom LE; Ficociello LH; Smiles AM; Warram JH; Krolewski AS; Perkins BA
    Clin J Am Soc Nephrol; 2015 Jul; 10(7):1136-44. PubMed ID: 26092828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of non-carboxymethyllysine advanced glycation endproducts are correlated to severity of microvascular complications in patients with Type 1 diabetes.
    Miura J; Yamagishi Si; Uchigata Y; Takeuchi M; Yamamoto H; Makita Z; Iwamoto Y
    J Diabetes Complications; 2003; 17(1):16-21. PubMed ID: 12505751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Degradation products of proteins damaged by glycation, oxidation and nitration in clinical type 1 diabetes.
    Ahmed N; Babaei-Jadidi R; Howell SK; Beisswenger PJ; Thornalley PJ
    Diabetologia; 2005 Aug; 48(8):1590-603. PubMed ID: 15988580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of renal damage markers in the diagnosis of early stages of kidney injury in patients with latent autoimmune diabetes in adults.
    Tsaryk I; Pashkovska N
    J Med Life; 2022 Jun; 15(6):792-796. PubMed ID: 35928354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early nephropathy in type 1 diabetes: the importance of early renal function decline.
    Perkins BA; Krolewski AS
    Curr Opin Nephrol Hypertens; 2009 May; 18(3):233-40. PubMed ID: 19300247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.